6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
2m ago	Nayax to Report 2026 Q1 Earnings on May 12, 2026
29m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine

About

Immunovant Inc (NASDAQ:IMVT) — investor relations, events, news, and company updates on 6ix.

Latest News

Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025

Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

Immunovant Announces Pricing of $550 Million Common Stock Financing

Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025

Financials

Revenue

$0

Market Cap

$5.22 B

EPS

-2.67

Community Chat

Ask AI